from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3854c/ethA

LFCtreatmentdescriptionclass of inhibitor

-1.112

Amikacinug/mL Amikacintranslation

-0.611

Cap5-10ug/mL Capreomycintranslation

-0.847

Rox10-50 ug/mL Roxithromycintranslation

-0.735

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.557

Rif0.2-5ug/mL Rifampicintranscription

-0.394

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.328

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.446

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.430

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.441

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.836

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.885

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.747

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.044

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.435

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.408

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.305

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.160

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.757

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.815

KCN5-20 ug/mL Potassium cyaniderespiration

-0.272

NaN30.2-2 mM Sodium aziderespiration

0.253

Nigericin50 uM Nigericinrespiration

1.026

TRC10-150 ug/mL Triclosanrespiration

0.078

TRZ10-25 ug/mL Thioridazinerespiration

0.297

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.634

menadione6-10 ug/mL Menadionerespiration

-0.991

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.710

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.313

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.933

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.121

NRP_1Non-replicating persistence stage 1dosRassociated

-0.434

Amp0.2mg/mL AmpicillincellWall

-0.317

Cephalexin20-100 ug/mL CephalexincellWall

-0.357

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.486

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.102

EMB10-20 ug/mL EthambutolcellWall

0.007

Eta12-40 ug/mL EthionamidecellWall

-0.170

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.474

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.998

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.242

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.718

BZA0.12 mg/mL BenzamidearomaticAmides

0.631

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.596

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.434

H2O24 mM hydrogen peroxideDNAdamaging

-0.775

Levo10 ug/mL LevofloxacinDNAdamaging

-0.559

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.735

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.890

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.477

UVUV-irradiationDNAdamaging

-0.476

ARP41-4 ug/mL Antitubercular compound ARP4?

0.433

Antimycin12.5-50 ug/mL Antimycin A?

-0.487

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.928

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.875

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.493

PA8240.2-2 ug/mL PA-824?

1.959

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.234

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.493

Verapamil50 uM Verapamil?

-0.077

mercaptoethanol2 mM 2-Mercaptoethanol?

0.467

methoxatin10-20 ug/mL Methoxatin?